versión imprimible
 
 

2nd Annual RNAi-Based Therapeutics Summit - June 2021 - Digital Event

Evvnt Promotion / evvnt
-
15.06.2021 - 17.06.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Temas de la conferencia
As investments and collaborations hit a record high, the RNAi therapeutics industry continues to rapidly expand. With RNAi drugs prevailing as a therapy with huge potential against liver diseases, exciting efforts have now turned to a wide range of other diseases, from CNS, oncology, metabolism and more. Despite the growing momentum, much needs to be addressed in terms of targeted delivery, safety, and efficiency to fully unleash the therapeutic value of RNAi drugs.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Greg Hinkle Vice President, Research Informatics Alnylam Pharmaceuticals, Ekkehard Leberer Senior Director, R&D Alliance Management Sanofi, Julia Alterman Senior Scientist Khvorova Lab University of Massachusetts Medical School and more
 

Información e inscripción:

https://go.evvnt.com/733422-0?pid=4832
Mr. Customer Service
 
Categorías
Medicina General, Salud Pública
Idioma
Inglés
Cuota del Congreso
Conference Only: USD 1999.00, Conference + 1 Workshop: USD 2348.00, Conference + 2 Workshops: USD 2697.00
Los participantes esperaban
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Center of ExcellenceÄrztekammer für WienÖsterreichische Akademie der ÄrzteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioHelix - Forschung & Beratung WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinAlumni Club Medizinische Universität WienÖsterreichische Gesellschaft für Public Health